{"id":5672,"date":"2017-08-24T20:10:55","date_gmt":"2017-08-25T00:10:55","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/accutane\/"},"modified":"2023-02-27T14:22:46","modified_gmt":"2023-02-27T19:22:46","slug":"precis","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/fr\/domaines-de-pratique-2\/precis\/","title":{"rendered":"Accutane"},"content":{"rendered":"<h2 class=\"update-highlight\" style=\"text-align: center; background-color: red;\">NOUS N&#039;ACCEPTONS PLUS LES CAS ACCUTANE<\/h2>\n<p>Approuv\u00e9 pour la premi\u00e8re fois par la Food and Drug Administration (FDA) des \u00c9tats-Unis en 1982 pour le traitement de l&#039;acn\u00e9 s\u00e9v\u00e8re, Accutane, l&#039;ingr\u00e9dient actif isotr\u00e9tino\u00efne, a des dizaines d&#039;effets secondaires dangereux. Retir\u00e9 du march\u00e9 par le fabricant d&#039;Accutane, Hoffman-LaRoche, Inc. en 2009, il existe de nombreux m\u00e9dicaments g\u00e9n\u00e9riques contenant de l&#039;isotr\u00e9tino\u00efne qui sont encore disponibles pour les patients aujourd&#039;hui. Si vous avez pris de l&#039;Accutane ou de l&#039;isotr\u00e9tino\u00efne et que vous en avez subi un pr\u00e9judice, vous pouvez avoir une cause d&#039;action contre le fabricant du m\u00e9dicament dangereux.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>Les dangers de l&#039;accutane<\/strong><\/h3>\n<p>La prise d&#039;Accutane et d&#039;autres m\u00e9dicaments contenant de l&#039;isotr\u00e9tino\u00efne a \u00e9t\u00e9 li\u00e9e \u00e0 une multitude de probl\u00e8mes de sant\u00e9 graves. Selon un <a href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/ucm085812.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Guide des m\u00e9dicaments Accutane fourni par la FDA<\/a>, les risques d&#039;Accutane comprennent\u00a0:<\/p>\n<ul>\n<li>Malformations cong\u00e9nitales;<\/li>\n<li>D\u00e9pression;<\/li>\n<li>Psychose;<\/li>\n<li>Suicide;<\/li>\n<li>Probl\u00e8mes c\u00e9r\u00e9braux graves (y compris convulsions et accidents vasculaires c\u00e9r\u00e9braux);<\/li>\n<li>Probl\u00e8mes de peau;<\/li>\n<li>Saignement rectal;<\/li>\n<li>Douleur intestinale\u00a0;<\/li>\n<li>Probl\u00e8mes osseux et musculaires;<\/li>\n<li>Probl\u00e8mes auditifs et visuels;<\/li>\n<li>Augmentation des lipides sanguins\u00a0;<\/li>\n<li>Diab\u00e8te;<\/li>\n<li>Diminution du nombre de globules rouges et blancs\u00a0; et<\/li>\n<li>R\u00e9action allergique grave.<\/li>\n<\/ul>\n<p>D&#039;autres m\u00e9dicaments g\u00e9n\u00e9riques qui contiennent de l&#039;isotr\u00e9tino\u00efne comprennent Amnreason, Claravis et Sotret.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>Qui est responsable des dommages caus\u00e9s par Accutane\u00a0?<\/strong><\/h3>\n<p>There are multiple parties who may be held liable in civil litigation for harm caused by Accutane. Most commonly, a drug\u2019s manufacturer is held liable for harm caused to patients as a direct result of the drug. In fact, Hoffman-LaRoche, Inc. has already been ordered to pay more than $50 million to Accutane victims. Other parties who may be held liable in <a class=\"wpil_keyword_link\" href=\"https:\/\/napolilaw.lemonadestand.org\/fr\/domaines-de-pratique-2\/contentieux-pharmaceutique\/\" title=\"contentieux pharmaceutique\" data-wpil-keyword-link=\"linked\" data-wpil-monitor-id=\"70\">contentieux pharmaceutique<\/a> include a drug distributor, a doctor, a hospital, a pharmacist, or a pharmacy.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>Appelez un avocat en mati\u00e8re de drogue d\u00e9fectueux maintenant\u00a0!<\/strong><\/h3>\n<p>Lorsqu&#039;un m\u00e9dicament d\u00e9fectueux vous cause un pr\u00e9judice, vous avez le droit de d\u00e9poser une demande de dommages-int\u00e9r\u00eats. Une consultation avec un expert <a href=\"\/fr\/domaines-de-pratique-2\/contentieux-pharmaceutique\/\">avocat contentieux pharmaceutique<\/a> peut vous aider \u00e0 en savoir plus sur ce que vous devez savoir. Chez Napoli Shkolnik, PLLC, notre \u00e9quipe est pr\u00eate \u00e0 vous rencontrer aujourd&#039;hui. Pour en savoir plus, n&#039;attendez plus pour nous appeler pour demander une consultation.<\/p>","protected":false},"excerpt":{"rendered":"<p>WE ARE NO LONGER ACCEPTING ACCUTANE CASES First approved by the U.S. Food and Drug Administration (FDA) in 1982 for treatment of severe acne, Accutane\u2014active ingredient isotretinoin\u2014has dozens of dangerous&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":40,"template":"","practiceareas_category":[743],"class_list":["post-5672","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":1,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5672\/revisions"}],"predecessor-version":[{"id":18252,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5672\/revisions\/18252"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/media?parent=5672"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas_category?post=5672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}